| scholarly article | Q13442814 |
| P50 | author | Hans W. Kosterlitz | Q115018 |
| P2093 | author name string | M G Gillan | |
| P2860 | cites work | Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia | Q24613589 |
| Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors | Q34252505 | ||
| Novel opiate binding sites selective for benzomorphan drugs | Q35396728 | ||
| Comparison of the binding characteristics of tritiated opiates and opioid peptides | Q36096882 | ||
| Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain | Q36127850 | ||
| Multiple Neurotransmitter Receptors | Q40123055 | ||
| 3H-ethylketocyclazocine binding: Lack of evidence for a separate κ receptor in rats CNS | Q40285609 | ||
| Characterization of opioid receptors in nervous tissue | Q44352061 | ||
| Bremazocine: A potent, long-acting opiate kappa-agonist | Q46629270 | ||
| The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties | Q46698394 | ||
| Multiple opiate receptors: Differential binding of μ, κ and δ agonists | Q49151034 | ||
| High affinity binding of [3H]ethylketocyclazocine to rat brain homogenate | Q72148483 | ||
| Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors | Q72859601 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 461-469 | |
| P577 | publication date | 1982-11-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain | |
| P478 | volume | 77 |
| Q33652922 | "DAKLI": a multipurpose ligand with high affinity and selectivity for dynorphin (kappa opioid) binding sites |
| Q44341647 | A kinetic analysis of kappa-opioid agonist binding using the selective radioligand [3H]U69593. |
| Q48842395 | A method for dissecting two site receptor interactions in ligand binding studies |
| Q44341528 | Activation of opioid receptors in the mediobasal hypothalamus stimulates prolactin secretion in the conscious rat. |
| Q44346166 | Affinity of naloxone and its quaternary analogue for avian central delta and mu opioid receptors |
| Q44345342 | Alanine scan of the opioid peptide dynorphin B amide. |
| Q44332484 | Analgesia induced by electroacupuncture of different frequencies is mediated by different types of opioid receptors: another cross-tolerance study |
| Q32144645 | Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice |
| Q44343086 | Antinociceptive role of oxytocin in the nucleus raphe magnus of rats, an involvement of μ-opioid receptor |
| Q70169154 | Autoradiographic localization of opiate κ receptors in the rat spinal cord |
| Q44330992 | Binding Capacities and Affinities AT μ-, ∂- And k-Opioid Sites in Membrane Suspensions from Guinea-Pig Brain Regions |
| Q34106461 | Binding and neuropharmacological profile of zaleplon, a novel nonbenzodiazepine sedative/hypnotic |
| Q28366271 | Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors |
| Q31133668 | Brown adipose tissue thermogenesis contributes to fentanyl-evoked hyperthermia |
| Q28330836 | CI-977, a novel and selective agonist for the kappa-opioid receptor |
| Q54212490 | COMMUNICATIONS |
| Q44337506 | Characterization of opioid binding sites in the neural and intermediate lobe of the rat pituitary gland by quantitative receptor autoradiography |
| Q42028750 | Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo |
| Q37744084 | Chimeric opioid peptides: tools for identifying opioid receptor types |
| Q69845256 | Chronic sweet intake lowers pain thresholds without changing brain mu- or delta-opiate receptors |
| Q46223720 | Comparative binding properties of linear and cyclic delta-selective enkephalin analogues: [3H]-[D-Thr2, Leu5] enkephalyl-Thr6 and [3H]-[D-Pen2, D-Pen5] enkephalin |
| Q48710790 | Comparison of the filtration and centrifugation methods for assaying [3H](D-ala2, D-leu5)enkephalin binding to mouse brain membranes |
| Q37396166 | Control by cations of opioid binding in guinea pig brain membranes |
| Q37704393 | Dextrorphan binds to opioid receptors in guinea-pig brain membranes and is an antagonist at opioid receptors in myenteric plexus |
| Q44345911 | Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides |
| Q41348507 | Differences in the characteristics of opioid receptor binding in the rat and marmoset |
| Q35756851 | Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution |
| Q44347916 | Differential maturation of mu and delta opioid receptors in the chick embryonic brain |
| Q69831793 | Differential regulation of mu-opiate receptors in heroin- and morphine-dependent rats |
| Q24681935 | Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists |
| Q44346639 | Distinct subtypes of the opioid receptor with allosteric interactions in brain membranes |
| Q69894422 | Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster |
| Q44342633 | Distribution of opioid binding sites in spinal cord |
| Q35754763 | Effects of cations on binding, in membrane suspensions, of various opioids at mu-sites of rabbit cerebellum and kappa-sites of guinea-pig cerebellum |
| Q44331092 | Effects of selective receptor agonists and antagonists during myocardial ischaemia |
| Q44332255 | Electron microscopic localization of photoaffinity-labelled delta opioid receptors in the neostriatum of the rat |
| Q56972255 | Enkephalin affects ion transport via the enteric nervous system in guinea-pig ileum |
| Q48704954 | Evaluation of the interactions of mu and delta selective ligands with [3H]D-ala2-D-Leu5-enkephalin binding to mouse brain membranes |
| Q35888409 | Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin |
| Q45857077 | Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro |
| Q44347658 | Guanine nucleotide and cation regulation of mu, delta, and kappa opioid receptor binding: evidence for differential postnatal development in rat brain |
| Q37271334 | Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes |
| Q44344928 | Heterogeneity of opioid receptor binding in brain slices |
| Q34560840 | Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain |
| Q44546947 | Involvement of oxytocin in spinal antinociception in rats with inflammation |
| Q30602864 | Isolation and characterization of a novel conus peptide with apparent antinociceptive activity |
| Q48451544 | Kappa-binding and degradation of [3H]dynorphin A (1-8) and [3H]dynorphin A (1-9) in suspensions of guinea pig brain membranes |
| Q44330177 | Kappa-opioid receptor stimulation increases the expression of Na+-H+ exchange gene in the heart |
| Q44351592 | Kinetic evidence for differential agonist and antagonist binding to bovine hippocampal synaptic membrane opioid receptors |
| Q28181106 | Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111) |
| Q44336066 | Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study |
| Q43921855 | Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons |
| Q48132136 | Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats |
| Q35027469 | Neuroregulation of mucus secretion by opioid receptors and K(ATP) and BK(Ca) channels in ferret trachea in vitro |
| Q44331304 | Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization study |
| Q39643197 | Opiate antagonists and rewarding brain stimulation |
| Q72413592 | Opiate binding in the rat spinal cord: Evidence for mu and delta sites |
| Q44330739 | Opioid Control of the In Vitro Release of Cholecystokinin‐Like Material from the Rat Substantia Nigra |
| Q35049029 | Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence |
| Q44351433 | Opioid binding sites of the κ-type in guinea-pig cerebellum |
| Q44334340 | Opioid control of the release of Met-enkephalin-like material from the rat spinal cord |
| Q41847050 | Opioid inhibition of nicotine-induced 45ca2+-uptake into cultured bovine adrenal medullary cells |
| Q72957867 | Opioid receptors in midbrain dopaminergic regions of the rat. I. Mu receptor autoradiography |
| Q40590296 | Opioidergic control of the spinal release of neuropeptides. Possible significance for the analgesic effects of opioids |
| Q44339346 | Opposite effects of delta and mu opioid receptor agonists on the in vitro release of substance P-like material from the rat spinal cord |
| Q42849304 | PD117302: a selective agonist for the kappa-opioid receptor |
| Q58830766 | POSTER COMMUNICATIONS |
| Q58830770 | POSTER COMMUNICATIONS |
| Q48761236 | Peptide E: Opiate receptor binding profile in the rat brain membrane assay. Comparison with beta-endorphin |
| Q35755650 | Perinatal lead exposure alters the development of delta- but not mu-opioid receptors in rat brain |
| Q42043194 | Pharmacological profile of various κ-agonists at κ-, μ- and δ-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain |
| Q35100925 | Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex |
| Q71764767 | Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity |
| Q44348509 | Receptor-mediated activation of G-proteins by kappa opioid agonists in frog (Rana esculenta) brain membranes |
| Q42475044 | Regulation of L-valine absorption by opioids interacting with mu-receptors in rabbit ileum |
| Q42568757 | Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat. |
| Q44345215 | Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain |
| Q36004219 | Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor |
| Q38677168 | Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin |
| Q45965980 | Synthesis and in vitro Evaluation of Trifluoroethylamine Analogues of Enkephalins. |
| Q34223951 | Synthesis of novel diazatricyclodecanes (DTDs). Effects of structural variation at the C3' allyl end and at the phenyl ring of the cinnamyl chain on mu-receptor affinity and opioid antinociception |
| Q33929349 | Synthesis, modelling, and mu-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicycl |
| Q92684608 | Testosterone modulation of ethanol effects on the µ-opioid receptor kinetics in castrated rats |
| Q44333895 | The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain |
| Q44337992 | The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation |
| Q37009870 | The prenatal developmental profile of expression of opioid peptides and receptors in the mouse brain |
| Q36003985 | The use of [3H]-[D-Pen2,D-Pen5]enkephalin as a highly selective ligand for the delta-binding site |
| Q48598777 | The use of computer analysis in describing multiple opiate receptors |
| Q41872646 | Unexpected prosecretory action component of loperamide at mu-opioid receptors in the guinea-pig colonic mucosa in vitro |
| Q33929513 | Urinary excretion of morphine and biosynthetic precursors in mice |
| Q46305248 | VV-hemorphin-7 and LVV-hemorphin-7 released during in vitro peptic hemoglobin hydrolysis are morphinomimetic peptides |
| Q46579938 | [3H]diprenorphine binding to kappa-sites in guinea-pig and rat brain: evidence for apparent heterogeneity |
| Q72411095 | κ-opiates and urination: Pharmacological evidence for an endogenous role of the κ-opiate receptor in fluid and electrolyte balance |
| Q44333594 | μ- and κ-opioid receptor-meiated opioid effects on social play in juvenile rats |
Search more.